CNX-774
CNX-774 is an orally active, irreversible and selective BTK inhibitor, with an IC50 of [1][2].
Product Specifications
CAS Number
1202759-32-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CNX-774.html
Purity
99.92
Solubility
DMSO : ≥ 45 mg/mL
Smiles
O=C(NC)C1=NC=CC(OC2=CC=C(NC3=NC=C(F)C(NC4=CC=CC(NC(C=C)=O)=C4)=N3)C=C2)=C1
Molecular Formula
C26H22FN7O3
Molecular Weight
499.50
Precautions
H302, H315, H319, H335
References & Citations
[1]Matthew Labenski, et al. In Vitro Reactivity Assessment of Covalent Drugs Targeting Bruton's Tyrosine Kinase.|[2]Akintunde Akinleye, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol. 2013 Aug 19;6:59.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY402346 100 µg
Grainyhead like protein 1 homolog (GRHL1) (NM_014552) Human Over-expression Lysate
Sign In for Pricing
View Details ![Transcription factor AP-2-alpha Recombinant Rabbit Monoclonal Antibody [PSH02-06]](https://cdn.genprice.uk/products/992/68dd1c8a061270361ea80ec3/imageurl/ha721765.webp)
HA721765 100 µL
Transcription factor AP-2-alpha Recombinant Rabbit Monoclonal Antibody [PSH02-06]
Sign In for Pricing
View Details 
